Advanced Medical Electronic Corp

Operational for more than 25 years, Boston Scientific Corporation is a developer, manufacturer and marketer of devices that are used in a range of interventional medical specialties throughout the world. It has a staff of more than 25,000 employees. The company operates over 25 manufacturing, distribution and technology centers. Boston Scientific Corporation delivers nearly 13,000 products in more than 45 countries. It contributes more than $25 million annually to research, education and local communities. The company specializes in developing microelectronic technologies to treat disabling disorders, such as deafness and chronic pain. Boston Scientific Corporation s products include Convoy advanced delivery sheath kits, AFocus steerable diagnostic catheters and implantable cardioverter defibrillators

Headquartered in Plymouth, Minn., ev3 is a medical device company with an international customer base. The company is focused on developing endovascular technologies for minimally invasive treatments of cardiovascular, neurovascular and peripheral vascular diseases and disorders. The company s peripheral, peripheral vascular and cardio-peripheral devices are available in the United States, while its peripheral vascular and cardio-peripheral devices are available internationally. The company s products include self-expanding, balloon-expandable and un-mounted balloon-expandable stents; balloon angioplasty catheters; guide-wires, snares and accessories; thrombus management systems; and embolic protection devices. A public company, ev3 s shares are listed on the NASDAQ Stock Market under the ticker symbol EVVV.

NAMSA, a global leader in medical device testing and consulting, has been serving the industry since its founding in 1967. With a dedicated team of 1,400 professionals across North America, Europe, and Asia, NAMSA offers unparalleled expertise in preclinical research, clinical trials, and regulatory compliance for over 100,000 medical devices each year. The company provides a comprehensive suite of services, including biocompatibility testing, clinical trial management, and strategy consulting, ensuring patient safety and device efficacy. Trusted by the US FDA and other global regulatory authorities, NAMSA delivers a holistic view of the regulatory pathway, streamlining the process from concept to commercialization for its clients worldwide. Generated from the website